A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer

Conditions: Vulvar and Vaginal Cancer Interventions: Drug: Cardunolizumab Sponsors: Zhejiang Cancer Hospital; Akeso; Innovent Biologics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials